194 related articles for article (PubMed ID: 36630458)
1. New insight into Epstein-Barr virus infection using models of stratified epithelium.
Hayman IR; Temple RM; Burgess CK; Ferguson M; Liao J; Meyers C; Sample CE
PLoS Pathog; 2023 Jan; 19(1):e1011040. PubMed ID: 36630458
[TBL] [Abstract][Full Text] [Related]
2. Efficient replication of Epstein-Barr virus in stratified epithelium in vitro.
Temple RM; Zhu J; Budgeon L; Christensen ND; Meyers C; Sample CE
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16544-9. PubMed ID: 25313069
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr Virus Glycoprotein BDLF2 Is Essential for Efficient Viral Spread in Stratified Epithelium.
Walston JJ; Hayman IR; Gore M; Ferguson M; Temple RM; Liao J; Alam S; Meyers C; Tugizov SM; Hutt-Fletcher L; Sample CE
J Virol; 2023 Feb; 97(2):e0152822. PubMed ID: 36688650
[TBL] [Abstract][Full Text] [Related]
4. Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells.
Caves EA; Cook SA; Lee N; Stoltz D; Watkins S; Shair KHY
mSphere; 2018 Jul; 3(4):. PubMed ID: 30021875
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma Protein Is Required for Epstein-Barr Virus Replication in Differentiated Epithelia.
Myers JE; Schaal DL; Nkadi EH; Ward BJH; Bienkowska-Haba M; Sapp M; Bodily JM; Scott RS
J Virol; 2023 Feb; 97(2):e0103222. PubMed ID: 36719239
[TBL] [Abstract][Full Text] [Related]
6. Generation and Infection of Organotypic Cultures with Epstein-Barr Virus.
Temple RM; Meyers C; Sample CE
Methods Mol Biol; 2017; 1532():65-78. PubMed ID: 27873267
[TBL] [Abstract][Full Text] [Related]
7. A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor- and cell type-specific susceptibility to Epstein-Barr virus infection.
Ziegler P; Tian Y; Bai Y; Abrahamsson S; Bäckerholm A; Reznik AS; Green A; Moore JA; Lee SE; Myerburg MM; Park HJ; Tang KW; Shair KHY
PLoS Pathog; 2021 Apr; 17(4):e1009041. PubMed ID: 33914843
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase.
Niedobitek G; Young LS; Lau R; Brooks L; Greenspan D; Greenspan JS; Rickinson AB
J Gen Virol; 1991 Dec; 72 ( Pt 12)():3035-46. PubMed ID: 1662695
[TBL] [Abstract][Full Text] [Related]
9. Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells.
Nawandar DM; Wang A; Makielski K; Lee D; Ma S; Barlow E; Reusch J; Jiang R; Wille CK; Greenspan D; Greenspan JS; Mertz JE; Hutt-Fletcher L; Johannsen EC; Lambert PF; Kenney SC
PLoS Pathog; 2015 Oct; 11(10):e1005195. PubMed ID: 26431332
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus latent and replicative gene expression in oral hairy leukoplakia.
Sandvej K; Krenács L; Hamilton-Dutoit SJ; Rindum JL; Pindborg JJ; Pallesen G
Histopathology; 1992 May; 20(5):387-95. PubMed ID: 1316871
[TBL] [Abstract][Full Text] [Related]
11. Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids.
Wallaschek N; Reuter S; Silkenat S; Wolf K; Niklas C; Kayisoglu Ö; Aguilar C; Wiegering A; Germer CT; Kircher S; Rosenwald A; Shannon-Lowe C; Bartfeld S
PLoS Pathog; 2021 Feb; 17(2):e1009210. PubMed ID: 33596248
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus transcytosis through polarized oral epithelial cells.
Tugizov SM; Herrera R; Palefsky JM
J Virol; 2013 Jul; 87(14):8179-94. PubMed ID: 23698302
[TBL] [Abstract][Full Text] [Related]
13. Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells.
Lin Z; Swan K; Zhang X; Cao S; Brett Z; Drury S; Strong MJ; Fewell C; Puetter A; Wang X; Ferris M; Sullivan DE; Li L; Flemington EK
J Virol; 2016 Jan; 90(7):3469-79. PubMed ID: 26764001
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers.
Pegtel DM; Middeldorp J; Thorley-Lawson DA
J Virol; 2004 Nov; 78(22):12613-24. PubMed ID: 15507648
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation.
Walling DM; Ray AJ; Nichols JE; Flaitz CM; Nichols CM
J Virol; 2007 Jul; 81(13):7249-68. PubMed ID: 17376908
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection.
Shannon-Lowe C; Rowe M
PLoS Pathog; 2011 May; 7(5):e1001338. PubMed ID: 21573183
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells.
Tsang CM; Deng W; Yip YL; Zeng MS; Lo KW; Tsao SW
Chin J Cancer; 2014 Nov; 33(11):549-55. PubMed ID: 25223910
[TBL] [Abstract][Full Text] [Related]
18. CD21-Dependent infection of an epithelial cell line, 293, by Epstein-Barr virus.
Fingeroth JD; Diamond ME; Sage DR; Hayman J; Yates JL
J Virol; 1999 Mar; 73(3):2115-25. PubMed ID: 9971794
[TBL] [Abstract][Full Text] [Related]
19. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
Zhang J; Jia L; Tsang CM; Tsao SW
Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
[TBL] [Abstract][Full Text] [Related]
20. CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells.
Smith NA; Coleman CB; Gewurz BE; Rochford R
J Virol; 2020 May; 94(11):. PubMed ID: 32238579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]